Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.2K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.2K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.1K
Rh Blood Group01:19

Rh Blood Group

1.8K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.8K
Hemoglobin01:24

Hemoglobin

4.3K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
4.3K
Blood Transfusion01:15

Blood Transfusion

792
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
792
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BDNF and GSK-3β signaling in depression: molecular mechanisms underlying neural plasticity dysfunction.

Molecular biology reports·2026
Same author

Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities.

Life sciences·2026
Same author

Pathophysiology of silent hypoxia in COVID-19: Truth and mystery.

Respiratory medicine·2026
Same author

Targeting of RhoA-ROCK pathway activators and linked molecular signaling in Alzheimer's disease: The paving dawn for future therapy.

Neuroscience·2026
Same author

Beyond categorical boundaries: Common molecular and cellular pathways in autism spectrum disorder and schizophrenia.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Role of 5α-reductase inhibitors in Parkinson's disease: Gambling or not?

The Journal of steroid biochemistry and molecular biology·2026

Related Experiment Video

Updated: Sep 5, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.9K

Hemolytic anemia in COVID-19.

Hayder M Al-Kuraishy1, Ali I Al-Gareeb1, Ajeet Kaushik2

  • 1Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, M.B.Ch.B, FRCP, Baghdad, Iraq.

Annals of Hematology
|July 8, 2022
PubMed
Summary

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) can cause hemolytic anemia through direct cell injury or autoimmune responses. Early detection and monitoring are crucial for managing this COVID-19 complication.

Keywords:
Autoimmune hemolytic anemiaCOVID-19SARS-CoV-2

More Related Videos

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.7K
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K

Related Experiment Videos

Last Updated: Sep 5, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.9K
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.7K
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K

Area of Science:

  • Hematology
  • Virology
  • Immunology

Background:

  • COVID-19, caused by SARS-CoV-2, is a global pandemic.
  • SARS-CoV-2 interacts with host cells via ACE2, CD147, and erythrocyte Band3 protein.
  • Hemolytic anemia is a recognized complication of COVID-19.

Purpose of the Study:

  • To comprehensively review the mechanisms linking SARS-CoV-2 infection to hemolytic anemia.
  • To highlight the direct and indirect pathways of erythrocyte injury.
  • To emphasize the importance of early diagnosis and management.

Main Methods:

  • Literature review of studies on SARS-CoV-2, hemolytic anemia, and related mechanisms.
  • Analysis of potential direct cytopathic effects of the virus on erythrocytes.
  • Examination of indirect mechanisms, including autoantibody induction.

Main Results:

  • SARS-CoV-2 can induce hemolytic anemia directly via cytopathic injury to erythrocytes.
  • Indirectly, SARS-CoV-2 infection can trigger autoimmune hemolytic anemia through autoantibody formation.
  • Hemolytic exacerbations may also occur due to COVID-19 treatments and vaccination.

Conclusions:

  • SARS-CoV-2 infection presents a dual risk for hemolytic anemia, through direct injury and autoimmune pathways.
  • Early detection and management of SARS-CoV-2-induced hemolytic anemia are vital for improving COVID-19 patient outcomes.
  • Ongoing monitoring for hemolytic complications is necessary, considering potential drug and vaccine-related exacerbations. Intelligent nanosystems show promise for early diagnosis.